GSK's shares rose 0.8% to £14.07 in London after the U.S. FDA granted priority review for its antibiotic Gepotidacin, targeting...

Gilead Sciences' biotech stock continues its upward trajectory as multiple investment banks raise price targets, buoyed by strong quarterly results...

Expedia's shares surged 13.5% to a 52-week high of $212.06 on Friday, capping a 59.75% annual gain, fueled by stronger-than-expected...

SoundHound AI, a leader in voice recognition technology, shattered expectations with its Q2 2025 performance, reporting revenue of $42.7 million—a...

Despite reporting solid second-quarter results, The Trade Desk’s shares plummeted over 30% in after-hours trading to $61.72, marking one of...

Bechtle's second-quarter earnings revealed a stark contrast between revenue growth and profit declines, leaving investors with mixed signals. The German...

Sony surprised markets with a robust comeback, reporting a 36% surge in operating profit to ¥340 billion ($2.3 billion) for...

Motorola Solutions surpassed analyst expectations with robust second-quarter results, reporting adjusted earnings of $3.57 per share—well above the projected $3.36—and...

Apple investors breathed a sigh of relief as the tech giant secured an exemption from proposed 100% tariffs on semiconductor...

Conocophillips delivered a paradoxical second-quarter performance, with record production volumes contrasting sharply with declining profits. The oil giant reported a...